Silvan Omerovic
Interventional Cardiology · Springfield, ILNPI 1356836738
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,989 of the $6,186 with a category attached, or 80.6%. It is spread thinly across 21 manufacturers, the largest accounting for just 21.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $2,041 and has fallen 60.7% since, to $801 in 2025. That places this record below the midpoint for interventional cardiology clinicians in IL, where the typical reported total is $7,434.
Across 138 payments — averaging $44.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$1K
- Amgen$759
- Boston Scientific$651
- Inari Medical, Inc.$532
- Shockwave Medical, Inc$426
- Pfizer$286
- plus $2K from 15 others
What the payments were for
- Travel & lodging$1,19819%
- Food & beverage$4,98981%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 9 | $1,350 |
| Amgen | 38 | $759 |
| Boston Scientific | 14 | $651 |
| Inari Medical, Inc. | 8 | $532 |
| Shockwave Medical, Inc | 3 | $426 |
| Pfizer | 14 | $286 |
| E.r. Squibb & Sons, L.L.C. | 9 | $284 |
| Merck | 9 | $282 |
| Abbott | 2 | $278 |
| AstraZeneca(2 entities) | 10 | $273 |
| Philips North America LLC | 3 | $172 |
| Stryker | 1 | $154 |
| Penumbra, Inc. | 1 | $141 |
| Boehringer Ingelheim | 5 | $103 |
| Terumo Medical Corporation | 3 | $103 |
| AbbVie | 2 | $99 |
| W. L. Gore & Associates, Inc. | 1 | $95 |
| Angiodynamics, Inc. | 2 | $80 |
| Chiesi USA, Inc. | 1 | $70 |
| Novartis | 2 | $32 |
| Teleflex LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,186 in reported general payments places this provider in the 40th percentile of 303 interventional cardiology providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BrilintaTicagrelor | 52 | $31,782 |
| EliquisApixaban | 40 | $31,514 |
| EntrestoSacubitril/Valsartan | 20 | $20,682 |
| FarxigaDapagliflozin Propanediol | 23 | $18,810 |
| JardianceEmpagliflozin | 20 | $9,538 |
| Atorvastatin Calcium | 113 | $1,210 |
| Ezetimibe | 20 | $1,065 |
| Metoprolol Succinate | 84 | $971 |
| ClopidogrelClopidogrel Bisulfate | 107 | $925 |
| Amiodarone Hcl | 28 | $629 |
| Spironolactone | 36 | $342 |
| Losartan Potassium | 42 | $340 |
| Bumetanide | 18 | $323 |
| Amlodipine Besylate | 49 | $261 |
| Potassium Chloride | 15 | $200 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaBrilinta, Farxiga | $273 | $50,59175 claims |
| PfizerEliquis | $286 | $31,51440 claims |
| NovartisEntresto | $32 | $20,68220 claims |
| Boehringer IngelheimJardiance | $103 | $9,53820 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 303 interventional cardiology providers in Illinois.
Other interventional cardiology in Springfield
- Tony de MartiniSpringfield$208K
- Shady HenienSpringfield$105K
- Donald YakelSpringfield$54K
- Jack HallSpringfield$40K
- Krishna Rocha SinghSpringfield$25K
- Andrei PopElk Grove Village$900K
- Atman ShahChicago$788K
- Ravi RamanaPalos Park$458K
- Mahesh RajuDowners Grove$281K
- Mark RicciardiEvanston$253K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.